Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Acta Oncologica (Stockholm, Sweden)|March 11, 2022
Anal cancer in Sweden 2015-2019. Implementation of guidelines, structural changes, national registry and early resultsAnders Johnsson, David Norman, Eva Angenete, et al.Applied and Environmental Microbiology|March 17, 2009
Molecular epidemiology and characterization of Campylobacter spp. isolated from wild bird populations in northern EnglandLaura A Hughes, Malcolm Bennett, Peter Coffey, et al.Neurobiology of Aging|June 18, 2005
Age effects on atrophy rates of entorhinal cortex and hippocampusAn-Tao Du, Norbert Schuff, Linda L Chao, et al.Neurobiology of Aging|January 18, 2005
White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophyAn-Tao Du, Norbert Schuff, Linda L Chao, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|September 6, 2007
FK506, a calcineurin inhibitor, prevents cadmium-induced testicular toxicity in miceLisa Joy Martin, Haiyan Chen, Xiaoyan Liao, et al.BMJ Open|August 15, 2018
Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocolMartin de Bock, Sybil A McAuley, Mary Binsu Abraham, et al.The Lancet. Oncology|January 14, 2021
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trialPer Fransson, Per Nilsson, Adalsteinn Gunnlaugsson, et al.Lancet (London, England)|June 23, 2019
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trialAnders Widmark, Adalsteinn Gunnlaugsson, Lars Beckman, et al.BMJ Open|May 6, 2025
Rationale and design of a randomised phase II multicentre crossover trial investigating a sodium-glucose co-transporter 2 inhibitor, dapagliflozin, combined with a novel continuous ketone monitor in adults with type 1 diabetes to reduce the risk of diabetic ketoacidosis: the PARTNER studyJennifer Ngan, Yee Wen Kong, Jenna Goad, et al.Journal of Diabetes Science and Technology|April 9, 2026
First in Human Feasibility Study of an Insulin Patch Pump Combined With CGM-Insulin Delivery CannulaHannah Cunningham, Hanna Jones, Steve Flint, et al.Pageof 5